Does ADALIMUMAB Cause Exposure during breast feeding? 215 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 215 reports of Exposure during breast feeding have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
215
Reports of Exposure during breast feeding with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
1
Deaths
51
Hospitalizations
How Dangerous Is Exposure during breast feeding From ADALIMUMAB?
Of the 215 reports, 1 (0.5%) resulted in death, 51 (23.7%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Exposure during breast feeding Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 215 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Exposure during breast feeding?
COPPER (412)
FLUOXETINE (122)
NEVIRAPINE (117)
BUPRENORPHINE (110)
LAMIVUDINE (102)
LEVONORGESTREL (102)
ZIDOVUDINE (93)
BUPRENORPHINE\NALOXONE (83)
NICOTINE (81)
INSULIN LISPRO (74)
Which ADALIMUMAB Alternatives Have Lower Exposure during breast feeding Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB